A resolution supporting the goals and ideals of a National Move Over Law Day.
- Last Action
- 12/3/2025
Actions
- 2025-04-10Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.
- 2025-04-10Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
- 2025-04-10Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
- 2025-04-03Committee on the Judiciary. Ordered to be reported without amendment favorably.
- 2025-02-11Read twice and referred to the Committee on the Judiciary.
- 2025-02-11Introduced in Senate
CRS Summary
As of 2025-02-11 (00)
Prescription Pricing for the People Act of 2025
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs.
The report must address whether pharmacy benefit managers (PBMs) (1) reimburse pharmacies owned by the PBM at a higher price than other pharmacies, and (2) implement formulary designs to increase the market share of higher-cost prescription drugs or depress the market share of lower-cost prescription drugs.
The FTC also must provide recommendations to increase transparency in the supply chain, prevent anticompetitive practices, and ensure that consumers benefit from cost savings or efficiencies that result from mergers and consolidations.
Additionally, the FTC must report the number and nature of complaints the FTC receives relating to an allegation of anticompetitive conduct by a manufacturer of a sole-source drug.
Cosponsors (13)
- Maria Cantwell (D-WA)
- Roger Marshall (R-KS)
- Peter Welch (D-VT)
- Tommy Tuberville (R-AL)
- Christopher Coons (D-DE)
- Thomas Tillis (R-NC)
- Richard Blumenthal (D-CT)
- Shelley Capito (R-WV)
- Mazie Hirono (D-HI)
- James Lankford (R-OK)
- John Boozman (R-AR)
- Marsha Blackburn (R-TN)
- Raphael Warnock (D-GA)
Subjects
- Business ethics
- Business records
- Competition and antitrust
- Congressional oversight
- Consumer affairs
- Health care costs and insurance
- Health information and medical records
- Inflation and prices
- Prescription drugs
- Retail and wholesale trades
- Supply chain
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.